Insulin analogues and severe hypoglycaemia in type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 96, Issue 1, 2012, Pages 17-23

  Kristensen, P L ^a,b   Hansen, L S ^a   Jespersen, M J ^b   Pedersen Bjergaard, U ^b   Beck Nielsen, H ^c,i   Christiansen, J S ^d,j   Norgaard K ^e   Perrild, H ^f   Parving, H H ^g,j   Thorsteinsson, B ^b,h   Tarnow, L ^a  

^a STENO DIABETES CENTER   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

^f BISPEBJERG HOSPITAL   (Denmark)

^g University of Copenhagen   (Denmark)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^j AARHUS UNIVERSITY   (Denmark)

more..

Author keywords

Insulin regimen; Severe hypoglycaemia; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; LONG ACTING INSULIN; SHORT ACTING INSULIN;

ADULT; ARTICLE; AWARENESS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; GLYCEMIC CONTROL; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK ASSESSMENT; TREATMENT DURATION;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, LONG-ACTING; MALE; MIDDLE AGED;

EID: 84858749175     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.10.046     Document Type: Article

References (24)

1. Pramming S., Thorsteinsson B., Bendtson I., Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991, 8:217-222.
2. Banck-Petersen P., Larsen T., Pedersen-Bjergaard U., Bie-Olsen L., Høi-Hansen T., Thorsteinsson B. Concerns about hypoglycaemia and late complications in patients with insulin-treated diabetes. Eur Diabetes Nurs 2007, 4:113-118.
3. Pouwer F., Hermanns N. Insulin therapy and quality of life. A review. Diabetes Metab Res Rev 2009, 25(Suppl. 1):S4-S10.
4. Fisher M., Frier B.M. Mortality, cardiovascular morbidity and possible effects of hypoglycaemia on diabetic complications. Hypoglycaemia in clinical diabetes 2007, 265-283. John Wiley & Sons Ltd., Chichester, England. B.M. Frier (Ed.).
5. Hammer M., Lammert M., Mejias S.M., Kern W., Frier B.M. Costs of managing severe hypoglycaemia in three European countries. J Med Econ 2009, 12:281-290.
6. Valentine W.J., Jendle J., Saraheimo M., Thorsteinsson B., Pollock R.F., Lammert M. Evaluating the cost-effectiveness of reduced mild hypoglycemia in subjects with type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and The Netherlands. Diabet Med 2011, [Epub ahead of print].
7. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997, 46:271-286. The DCCT Research Group.
8. Clarke W.L., Cox D.J., Gonder-Frederick L.A., Julian D., Schlundt D., Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995, 18:517-522.
9. MacLeod K.M., Hepburn D.A., Frier B.M. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 1993, 10:238-245.
10. Pedersen-Bjergaard U., Agerholm-Larsen B., Pramming S., Hougaard P., Thorsteinsson B. Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. Lancet 2001, 357:1248-1253.
11. Pedersen-Bjergaard U., Pramming S., Heller S.R., Wallace T.M., Rasmussen A.K., Jorgensen H.V., et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004, 20:479-486.
12. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007, 50:1140-1147. UK Hypoglycaemia Study Group.
13. Gough S.C. A review of human and analogue insulin trials. Diabetes Res Clin Pract 2007, 77:1-15.
14. Singh S.R., Ahmad F., Lal A., Yu C., Bai Z., Bennett H. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. CMAJ 2009, 180:385-397.
15. Heller S.R., Amiel S.A., Mansell P. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care 1999, 22:1607-1611.
16. Bartley P.C., Bogoev M., Larsen J., Philotheou A. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial. Diabet Med 2008, 25:442-449.
17. Home P.D., Rosskamp R., Forjanic-Klapproth J., Dressler A. A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes. Diabetes Metab Res Rev 2005, 21:545-553.
18. Heller S.R., Colagiuri S., Vaaler S., Wolffenbuttel B.H., Koelendorf K., Friberg H.H., et al. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes. Diabet Med 2004, 21:769-775.
19. Hermansen K., Madsbad S., Perrild H., Kristensen A., Axelsen M. Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy. Diabetes Care 2001, 24:296-301.
20. Deary I.J., Hepburn D.A., MacLeod K.M., Frier B.M. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia 1993, 36:771-777.
21. Pedersen-Bjergaard U., Pramming S., Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 2003, 19:232-240.
22. Hoi-Hansen T., Pedersen-Bjergaard U., Thorsteinsson B. Classification of hypoglycemia awareness in people with type 1 diabetes in clinical practice. J Diabet Complications 2009, 24:392-397.
23. Hilbe J.M. Negative binomial regression 2007, Cambridge University Press, Cambridge.
24. Signorello L.B., McLaughlin J.K., Lipworth L., Friis S., Sorensen H.T., Blot W.J. Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther 2002, 9:199-205.